9NNP image
Deposition Date 2025-03-05
Release Date 2025-11-19
Last Version Date 2025-11-19
Entry Detail
PDB ID:
9NNP
Title:
Composite structure of HSV-1 helicase-primase in complex with a forked DNA
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA replication helicase
Gene (Uniprot):HELI
Chain IDs:A
Chain Length:852
Number of Molecules:1
Biological Source:Human alphaherpesvirus 1 strain 17
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA primase
Gene (Uniprot):UL52
Chain IDs:B
Chain Length:1058
Number of Molecules:1
Biological Source:Human alphaherpesvirus 1 strain 17
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA helicase/primase complex-associated protein
Gene (Uniprot):UL8
Chain IDs:C
Chain Length:750
Number of Molecules:1
Biological Source:Human alphaherpesvirus 1 strain 17
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(P*TP*AP*CP*AP*TP*AP*A)-3')
Chain IDs:D
Chain Length:25
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural basis of herpesvirus helicase-primase inhibition by pritelivir and amenamevir.
Sci Adv 11 eadz1989 eadz1989 (2025)
PMID: 41202142 DOI: 10.1126/sciadv.adz1989

Abstact

Widespread herpesvirus infections are associated with various diseases. DNA replication of human herpes simplex virus type 1 (HSV-1) requires a helicase-primase (HP) complex of three core proteins: UL5, UL52, and UL8. This complex unwinds viral DNA and synthesizes primers for DNA replication, making it an attractive antiviral target. Although HP inhibitors pritelivir and amenamevir were identified through screening, their binding mechanisms remain unclear. Here, we report cryo-electron microscopy structures of HSV-1 HP bound to a forked DNA template alone and in complex with pritelivir or amenamevir. The structures reveal a bilobed architecture highlighting HP coordinated action at the replication fork and providing a structural basis for HP inhibition by illustrating precisely how pritelivir and amenamevir block helicase activity. Data lay a solid foundation for the development of improved antiviral therapies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback